USE OF DUAL H3/M2 ANTAGONISTS WITH A BIPIPERIDINIC STRUCTURE IN THE TREATMENT OF COGNITION DEFICIT DISORDERS

摘要

This invention relates to a method of treating cognition deficit disorders comprising administering to a mammal in need of such treatment an effective amount of a dual histamine HSUB3 /SUBreceptor antagonist/mSUB2 /SUBmuscarinic antagonist, or a combination of a histamine HSUB3 /SUBreceptor antagonist and a mSUB2 /SUBmuscarinic antagonist.